Association of bevacizumab plus oxaliplatin-based chemotherapy with disease-free survival and overall survival in patients with stage II colon cancer: A secondary analysis of the AVANT trial
Chibaudel, B., Henriques, J., Rakez, M., Brenner, B., Kim, T. W., Martinez-Villacampa, M., . . . Tabernero, J., de Gramont, … Read More
